Search Results

Your search matched 75 results


IBM Watson for Oncology | Blog

Originally built as a complement for a physician and not as a replacement, IBM Watson for Oncology launched a study to determine how closely the artificial intelligence computer and a panel of 12-15 multidisciplinary tumor board members could agree on treatment approaches.


Immuno-oncology is fundamentally changing what value means | In The Media

How will the pharma marketing, educational and service model adapt in response to redefined value in immuno-oncology?


Making the Most of Maturing Oncology Brands | In The Media

Our experts crafted a checklist for Pharmaceutical Executive that can be used to determine if there’s hidden vitality left in aging oncology brands and inspire outside-of-the-box, often low-investment solutions to grow the bottom line.


The Social Oncology Report: ASCO and Beyond | Blog

MDigitalLife (a division of the W20 Group) recently conducted an examination of specific cancer communities online.


Clearing a Commercial Path for Novel Cancer Therapeutics in a Post-Pandemic World | Perspectives

Part I of a Syneos Health Series on New Oncology Commercialization Strategies


Oncology Evaluates Its Relationship to Telehealth Post-Pandemic | Blog

As we’ve inched past the year mark of the pandemic, amidst the heartache of what has transpired and the fear of what is yet to come, there is an ironic undercurrent of collective chest-puffing—and rightly so.


Navicor | Agency

Full-service, oncology-focused advertising agency transforming products into brands and patients into survivors


Betting Big on | Blog

This month, Janssen launched, aiming to create an online destination for all things oncology.


GSW and Biosector 2 Are Shortlisted for 2019 MM&M Awards | In The Media

GSW and Biosector 2 are shortlisted for 2019 MM&M Awards for our client work with Endo Pharmaceuticals and Novartis Oncology.


Growing Number of Cancer Patients are Finding Limited Access to Care | Blog

In 2014, the American Society of Clinical Oncology (ASCO) released a landmark report about the state of cancer care in America.


New drugs, new money: Surge in cancer DTC ads follows wave of I-O debuts | In The Media

There's been a spike in oncology DTC advertising in recent years, thanks to new drugs and mechanisms of action – and Syneos Health™ has the research to prove it.



Noticing important shifts in the rules of engagement between industry and patient advocates, Syneos Health Public Relations Group conducted in-depth interviews with dozens of patient organizations in early 2015.


Future look: The Impact of Biosimilars on Oncology | In The Media

Ben Curtis and Katherine Seay, inVentiv Health Managed Markets comment on how strategies will adjust with the advent of biosimilars.


Getting Through to Oncologists Based on Their “Need for Cognition” | Blog

Take a cursory look at the agenda for next month’s ASCO, and you’ll see oncology’s newest innovations—and promise—come with ever-increasing complexity of choices.


Creating a Culture of Measurement | Blog

David Lennon, VP & Franchise Head for US Oncology at Novartis, showed the #efpphilly crowd where we’re at as an industry with technology and data and where our opportunities lie for greater collaboration.


Why the Pharmaceutical Revolutions of Tomorrow Will Start With the Science and Lead With a Great Story | Blog

More than 20 years ago, Gleevec ushered in a therapeutic revolution in oncology based on a relatively simple premise: If cancer cells are “addicted” to oncogenic mutations, targeting the troublesome protein might provide long-lasting disease control.


Using LinkedIn for micro-targeting oncologists | Blog

During this year’s Digital Pharma East conference, Stephanie Katzman, a healthcare strategist at LinkedIn, announced that the number of HCPs had grown from 3.5 million last year to over 5 million in the US alone and over 9 million globally in 2015.


CANCERCON : Because Young Adult Cancer Sucks | Blog

CANCERCON is the experience that you never knew you needed because who the hell thinks about cancer when you’re not eighty years old?


eyeforpharma Barcelona 2020: Insight Driven Patient-Centricity | Blog

Interested in how life science companies are approaching patient-centricity at eyeforpharma Barcelona 2020?


Inspiration in Pfizer's This Is Living With Cancer | Blog

Live from Cannes Lions: 9 people living with cancer + 6 months in their homes and lives = a story that shows it is possible to find a new normal


Vision 2020: Warm culture means healthy growth | Blog

It’s been mighty cold lately, hasn’t it?


A new approach to fighting drug shortages | Blog

Shortages of critical cancer-fighting drugs have impacted 83% of U.S. oncologists in the past six months.* Around the world, doctors are negotiating availability, access and funding for the infusions they most want to prescribe.


The Right Care in the Right Place at the Right Time | Blog

A daunting task for any doctor.


Tune in Doc-Virtual Conferences Are Now a Reality | Blog

2017 has marked a major shift in the way pharmaceutical giant Novartis will be using and expanding innovative digital platforms to share major congress experiences, education and medical information with physicians.


‘Value’: A Baker’s Dozen Fresh Quotes from Today’s Industry Execs | Blog

Live from EFP ‘18: The closing session for eyeforpharma ’18 brought the story full circle.


Oncologists Should Be Asking Patients, ‘Do You Even Lift?’ | Blog

A global alliance of 17 organizations, headed up by the American College of Sports Medicine (ACSM), published a report advising doctors to prescribe exercise to cancer patients.


GSK Gains Targeted Therapy, Footing in Boston with $5.1-billion Tesaro Buy | Blog

GlaxoSmithKline announced that it will acquire Waltham, Massachusetts-based drug company Tesaro, which develops novel cancer treatments, for $5.1 billion cash.


The Rise of Alternative Therapies and Their Potential to Impact Cancer Treatment | Blog

Complementary and alternative medicines (CAM) are therapies that are not considered the standard of care for a medical condition, and they represent $30 billion per year in consumer spending.


Wellness in the Workplace Turns to Genomic Testing | Blog

With healthcare expenses always seemingly on the rise, if you had the opportunity to reduce healthcare costs in your company by $1,464 annually per employee would you?